Verastem
VSTM
Verastem (VSTM) news
Recent news
Verastem - to issue $50 mln revenue notes on August 28, 2026 - SEC filing
AInvest Wire · Aug 7, 2026Verastem establishes initial notes of $75 mln and revenue notes up to $75 mln - SEC filing
AInvest Wire · Aug 7, 2026Verastem - enters amendment No. 3 to note purchase agreement on August 6, 2026 - SEC filing
AInvest Wire · Aug 7, 2026Verastem - initiates treatment in all three target-D Phase 2 trials
AInvest Wire · Jul 28, 2026Verastem - reports 86% overall survival rate at 6 months as of June 5, 2026
AInvest Wire · Jun 17, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.